Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Besse

Showing results (41-50 of 511) with videos related to

Pageof 52
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2018
Progress in the Management of Advanced Thoracic Malignancies in 2017Roberto Ferrara, Laura Mezquita, Benjamin Besse
European Respiratory Review : an Official Journal of the European Respiratory Society|October 7, 2021
The efficacy of immune checkpoint inhibitors in thoracic malignanciesJordi Remon, Francesco Facchinetti, Benjamin Besse
Bulletin Du Cancer|November 8, 2012
[Thymic epithelial neoplasms: updates on diagnosis, staging, biology and management in France]Julien Hadoux, Nicolas Girard, Benjamin Besse
Lancet (London, England)|September 9, 2016
Whole brain radiotherapy in patients with NSCLC and brain metastasesCécile Le Pechoux, Frederic Dhermain, Benjamin Besse
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2020
Current Panorama and Challenges for Neoadjuvant Cancer ImmunotherapyJose Carlos Benitez, Jordi Remon, Benjamin Besse
The Lancet. Oncology|March 5, 2013
What can be done for patients with NSCLC without druggable targets?Benjamin Besse, Fabrice Andre, Jean-Charles Soria
Bulletin Du Cancer|December 6, 2006
[Neoadjuvant chemotherapy in non small cell lung cancer]Benjamin Besse, Stéphane Vignot, Thierry Le Chevalier
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2020
To Continue or Not to Continue? That Is the QuestionMarina Chiara Garassino, Benjamin Besse, Valter Torri
BMC Medicine|March 14, 2017
Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?Jordi Remon, Benjamin Besse, Jean-Charles Soria
Translational Lung Cancer Research|December 4, 2018
Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapyLizza E Hendriks, Etienne Rouleau, Benjamin Besse
Pageof 52

Showing results (41-50 of 511) with videos related to

Sort By:
Pageof 52
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2018
Progress in the Management of Advanced Thoracic Malignancies in 2017Roberto Ferrara, Laura Mezquita, Benjamin Besse
European Respiratory Review : an Official Journal of the European Respiratory Society|October 7, 2021
The efficacy of immune checkpoint inhibitors in thoracic malignanciesJordi Remon, Francesco Facchinetti, Benjamin Besse
Bulletin Du Cancer|November 8, 2012
[Thymic epithelial neoplasms: updates on diagnosis, staging, biology and management in France]Julien Hadoux, Nicolas Girard, Benjamin Besse
Lancet (London, England)|September 9, 2016
Whole brain radiotherapy in patients with NSCLC and brain metastasesCécile Le Pechoux, Frederic Dhermain, Benjamin Besse
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2020
Current Panorama and Challenges for Neoadjuvant Cancer ImmunotherapyJose Carlos Benitez, Jordi Remon, Benjamin Besse
The Lancet. Oncology|March 5, 2013
What can be done for patients with NSCLC without druggable targets?Benjamin Besse, Fabrice Andre, Jean-Charles Soria
Bulletin Du Cancer|December 6, 2006
[Neoadjuvant chemotherapy in non small cell lung cancer]Benjamin Besse, Stéphane Vignot, Thierry Le Chevalier
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2020
To Continue or Not to Continue? That Is the QuestionMarina Chiara Garassino, Benjamin Besse, Valter Torri
BMC Medicine|March 14, 2017
Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?Jordi Remon, Benjamin Besse, Jean-Charles Soria
Translational Lung Cancer Research|December 4, 2018
Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapyLizza E Hendriks, Etienne Rouleau, Benjamin Besse
Pageof 52